Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last kr38.10 SEK
Change Today -0.40 / -1.04%
Volume 499.2K
KARO On Other Exchanges
Symbol
Exchange
OTC US
Stockholm
Frankfurt
As of 11:29 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Anders Waas

AgeTotal Calculated CompensationThis person is connected to 13 board members in 1 different organizations across 2 different industries.

See Board Relationships
58--

Background*

Mr. Anders Waas serves as Vice President of Business Development at CV Therapeutics (Now, Gilead Palo Alto, Inc). Mr. Waas served as a Director at Karo Bio Aktiebolag (publ) since July 13, 2011 and serves as a Member of the Biotech Investment Committee at Life Science Angels, Inc.

Corporate Headquarters*

Hälsovägen 7
Huddinge, Stockholm County 141 57

Sweden

Phone: 46 86 08 60 00
Fax: 46 87 74 82 61

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KARO:SS kr38.10 SEK -0.40

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KARO BIO AB, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.